NCT03888469

Brief Summary

The purpose of this study was to evaluate visual acuity at distance when wearing DDT2 contact lenses compared to Acuvue Moist contact lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 25, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

May 3, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 24, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 24, 2019

Completed
1 year until next milestone

Results Posted

Study results publicly available

June 25, 2020

Completed
Last Updated

June 25, 2020

Status Verified

June 1, 2020

Enrollment Period

2 months

First QC Date

March 22, 2019

Results QC Date

May 29, 2020

Last Update Submit

June 22, 2020

Conditions

Keywords

Visual acuityVADaily disposable contact lenses

Outcome Measures

Primary Outcomes (1)

  • Least Squares Mean Distance Visual Acuity With Study Lenses

    Visual acuity was assessed and collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal visual acuity), with a negative value denoting better than 20/20 visual acuity.

    Day 8, each product

Study Arms (2)

DDT2, then 1DAVM

OTHER

Verofilcon A contact lenses worn first, with etafilcon A contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) for 8 -1/+2 days in a daily disposable modality.

Device: Verofilcon A contact lensesDevice: Etafilcon A contact lenses

1DAVM, then DDT2

OTHER

Etafilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) for 8 -1/+2 days in a daily disposable modality.

Device: Verofilcon A contact lensesDevice: Etafilcon A contact lenses

Interventions

Investigational daily disposable soft contact lenses

Also known as: DDT2
1DAVM, then DDT2DDT2, then 1DAVM

Commercially available daily disposable soft contact lenses

Also known as: 1DAVM, 1-DAY ACUVUE® MOIST
1DAVM, then DDT2DDT2, then 1DAVM

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to understand and sign an Informed Consent Form that has been approved by an Institutional Review Board.
  • Willing and able to attend all scheduled study visits as required per protocol.
  • Current wearer of spherical soft contact lenses.

You may not qualify if:

  • Any ocular condition that contraindicates contact lens wear.
  • Previous or current habitual wearer of ACUVUE® MOIST or DAILIES TOTAL1® contact lenses.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Alcon Investigative Site

Jacksonville, Florida, 32256, United States

Location

Alcon Investigative Site

Maitland, Florida, 32751, United States

Location

Alcon Investigative Site

Orlando, Florida, 32803, United States

Location

Alcon Investigative Site

Powell, Ohio, 43065, United States

Location

Alcon Investigative Site

Memphis, Tennessee, 38111, United States

Location

MeSH Terms

Conditions

Refractive ErrorsMyopia

Condition Hierarchy (Ancestors)

Eye Diseases

Results Point of Contact

Title
CDMA Project Lead, Vision Care
Organization
Alcon Research, LLC

Study Officials

  • CDMA Project Lead, Vision Care

    Alcon Research

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2019

First Posted

March 25, 2019

Study Start

May 3, 2019

Primary Completion

June 24, 2019

Study Completion

June 24, 2019

Last Updated

June 25, 2020

Results First Posted

June 25, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations